Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?

Graphical Abstract Graphical Abstract S-ICD, subcutaneous ICD; TV-ICD, transvenous implantable cardioverter defibrillator; VF, ventricular fibrillation; VT, ventricular tachycardia. Created with BioRender.com.

[1]  P. Lambiase,et al.  Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion , 2023, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  J. Healey,et al.  Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations , 2022, Annals of Internal Medicine.

[3]  H. Calkins,et al.  Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right Ventricular Cardiomyopathy: A Comparison of Clinical and Quality-of-Life Outcomes. , 2022, JACC. Clinical electrophysiology.

[4]  T. Kurita,et al.  Anti-tachycardia pacing success in implantable cardioverter defibrillators by patient, device, and programming characteristics. , 2022, Heart rhythm.

[5]  Stefan L. Zimmerman,et al.  A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy , 2022, European heart journal.

[6]  H. Calkins,et al.  Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  F. Sacher,et al.  Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  J. Svendsen,et al.  Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[9]  Stefan L. Zimmerman,et al.  Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy , 2020, Circulation. Arrhythmia and electrophysiology.

[10]  A. Wilde,et al.  Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. , 2016, Heart rhythm.

[11]  M. Link,et al.  Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. , 2014, Journal of the American College of Cardiology.

[12]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.